Specifically, Oct4 can activate HIF-1α, leading to angiogenesis through VEGF activation [71], while AKT can modulate HIF-1α and VEGF protein expression through the PI3K/PTEN/AKT/FRAP during GBM development [73,74]. The gene discussed is HIF1A; the disease is glioblastoma.